• Return to Headlines

Shares of Biocryst Pharm Has Fallen Below Previous 52-Week Low

By David Diaz

Shares of Biocryst Pharm (NASDAQ:BCRX) traded at a new 52-week low today of $3.66. So far today approximately 15.5 million shares have been exchanged, as compared to an average 30-day volume of 953,000 shares.

Biocryst Pharm share prices have moved between a 52-week high of $9.95 and the current low of $3.66 and are currently at $3.66 per share. The 200-day and 50-day moving averages have moved 0.33% higher and 0.41% lower over the past week, respectively.

BioCryst Pharmaceuticals, Inc. designs, optimizes, and develops small-molecule novel pharmaceuticals that block key enzymes involved in infectious diseases, inflammatory diseases, and cancer. The Company has late-stage compounds in development and continues to discover additional compounds and to progress them to meet the unmet medical needs of patients and physicians.

Potential upside of 135.0% exists for Biocryst Pharm, based on a current level of $3.66 and analysts' average consensus price target of $8.60. The stock should run into initial resistance at its 200-day moving average (MA) of $7.93 and subsequent resistance at its 50-day MA of $8.01.

SmarTrend is tracking the current trend status for Biocryst Pharm and will alert subscribers who have BCRX in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows biocryst pharm

Ticker(s): BCRX